Literature DB >> 12955965

How the field of thyroid endocrinology developed in France after World War II.

Philippe Fragu.   

Abstract

This microhistory analyzes the transformation of French medical practice after World War II. Before the 1940s, coordinated clinical and experimental studies on a patient with thyroid disease were nonexistent. Starting in 1945, thyroid endocrinology was pushed forward by the use of radioiodine, which led pediatricians to rethink the hereditary transmission of thyroid diseases, stimulated by the school of biochemistry headed by Jean Roche, who participated in the elucidation of thyroid-hormone metabolism. Roche knew how to listen to hospital clinicians, who, in return, gave him free access to patients to conduct investigations on thyroid metabolism. Radioiodine proved to be sufficiently flexible to respond to the respective information needs of clinicians and biochemists, and was also responsible for the profound transformation of scientific reasoning: the chemical framework that had dominated thyroid studies since the discovery of thyroid iodine (1896) was replaced by the hormone paradigm.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12955965     DOI: 10.1353/bhm.2003.0063

Source DB:  PubMed          Journal:  Bull Hist Med        ISSN: 0007-5140            Impact factor:   1.314


  3 in total

1.  Peace propaganda and biomedical experimentation: influential uses of radioisotopes in endocrinology and molecular genetics in Spain (1947-1971).

Authors:  María Jesús Santesmases
Journal:  J Hist Biol       Date:  2006       Impact factor: 1.326

2.  Normal pathways: controlling isotopes and building biomedical research in postwar France.

Authors:  Jean-Paul Gaudillière
Journal:  J Hist Biol       Date:  2006       Impact factor: 1.326

Review 3.  Radioimmunotherapy: a specific treatment protocol for cancer by cytotoxic radioisotopes conjugated to antibodies.

Authors:  Hidekazu Kawashima
Journal:  ScientificWorldJournal       Date:  2014-10-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.